
    
      Participants are identified by administrative data and a model predicting high risk of future
      healthcare utilization. Participants are invited to the study by mail. After informed consent
      participants are randomized to either active treatment or control 3:1. Active patients have
      an in depth interview with a specially trained nurse. Further counselling by telephone weekly
      for 6-9 months.

      Quality of Life is measured by SF-36 every 3 months for one year both in active participants
      and in controls.
    
  